This case study shows the strong influence CCD-specific antibodies can have on test results. In this case, the automatic CCD-blocking of the ALEX test drastically reduced the number of clinically irrelevant results from 110 to 10.
ALEX² (Allergy Xplorer) is based on our proprietary nano-bead technology. Every allergen can be individually optimised for production. Our test panel is comprised of allergen extracts and molecular allergens and gives a comprehensive picture of each patient’s sensitisation status.